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DDiscussion
Dr David A. Fullerton (Aurora, Colo). Thank you very much.
Dr LaPar, I very much enjoyed your presentation and enjoyed
reading your report even more. It is extremely well written, and
it will be an excellent contribution to the data further defining
the relationship of surgeon volume and hospital center volume in
mitral valve surgical outcomes and the choice of operation.
I must confess that the sophisticated statistical method that you
used is a little over my head. I do not question it. I just have to
acknowledge up front that I do not fully understand it, and I
suspect that many who read the report will likewise have similar
questions. It is for that reason that I have a single question for
you. You have done a very nice job of demonstrating a threshold
of about 20 cases annually as being important in the surgeon’s
volume for defining, if you will, the percentage of mitral
valvuloplasties that are performed in that surgeon’s hands as
opposed to replacements. Yet, as one looks at the final graphs
that you displayed, one can see that even those surgeons who
have very low volumes per annum have identical rates of repair
as those that have very high rates or very high surgical volumes.
So I am curious as to how you might think this 20 cases per year
might actually play a role, and how might you help explain, then,
that even those centers and those surgeons with very low volumes
actually had very high rates of repair?
Thank you very much, and I enjoyed your report.
Dr LaPar. Thank you very much, Dr Fullerton, for those
questions and your kind comments.
The threshold that we observed of approximately 20 mitral
operations per year and the relationship to performance of mitral
repair is complimentary to several previous reports that have
examined trends in mitral surgery.
We, too, were surprised by the findings that the probability of
performing mitral operations was somewhat higher among very
low-volume surgeons performing between 0 and 5 operations
per year. We’re not quite sure exactly what motivations account
for this trend and unfortunately can’t draw any definitive
conclusions on this trend at this point without looking into the
practice patterns of these hospitals a little more closely.
When we looked into the data available to us for this study for
this subgroup of patients, we did notice some interesting trends
that are somewhat descriptive. We found that these patients had
very low predicted risk of mortalities—less than 1.2% for most
of them. We also found that these patients tended to have almost
exclusively moderate mitral regurgitation.
These findings may also represent the experience of relatively
young surgeons receiving senior mentorship for mitral repair at
some centers, but, because of the de-identified nature of this
data, this is truly speculative at this point.
Dr Lawrence H. Cohn (Boston, Mass). I just want to ask you
an obvious question. Is this type of study going to lead to the state
of Virginia dictating who and who will not be able to perform
mitral valve surgery in the future?The Journal of Thoracic and CarDr LaPar. That is certainly is an important question. I don’t
think it’s going to have too many direct policy implications
regarding treatment allocation in the state of Virginia, but I think
it does generally support what we’ve seen in the national data:
That surgeons who have expertise in certain areas are more likely
going to perform mitral repairs where appropriate.
Dr W. Randolph Chitwood (Greenville, NC). Damien, I
thought this was a great study, and it sort of parallels some of
the work that Jim Gammie did in the past. But the 1 point it
does not state, and neither does Jim Gammie’s report or any of
these reports, is what about the repairable valves? In other words,
repairable versus rheumatic versus, let us say, you are in a small
hospital and you have 15 cases coming in there, are these all
posterior leaflet P2 resections, which are fairly straightforward
and most can be repaired, or are they anterior leaflet resections?
So I think we must sometime study the data in our databases in
depth to know exactly what we are repairing and what we are not.
Because I would expect if you take the low-volume surgeons and
the low-volume centers with good results, that they are being smart
enough to take on the straightforward posterior leaflet cases, which
are 80% of the degenerative disease cases, and what about those
with rheumatic valves?
So your database, I do not believe separates this nor does our
national database. Thus, this is a cry, wouldn’t you say, especially
when Dave Adams presented a report yesterday about
guidelines and items of this nature. Because I guarantee you the
members of this organization, the European Association for
Cardio-Thoracic Surgery, and the STS would be up in arms if
someone mandated that one cannot repair a MV unless you have
done 25 MV repairs because some people do achieve excellent
results. So, comment on the pathophysiology.
Dr LaPar. I couldn’t agree more with you that a fundamental
limitation of a regional dataset like this, but also within the STS
national data, is a lack of information related to mitral valve etiol-
ogy and pathology. And, as you are aware, it is something that the
STS is really trying to improve in the new data-harvesting efforts.
Unfortunately, in this data, we can’t tease that out either in this
data because this is an analysis of a regional STS database.
Dr Chitwood. The sin is in your propensity matched patients,
only 50% were repaired. The European data show more. But still,
if you are considering repairable valves, almost 100% should be
repaired.
Dr Daniel H. Drake (Traverse City, Mich). I direct the
Michigan Society of Thoracic and Cardiovascular SurgeonsMitral
Initiative. I enjoyed your presentation immensely.
In Michigan, we have started to see internal referrals between
Society surgeons. The complexity of repair can be predicted
from the diagnostic transesophageal echocardiogram. After a
review of the transesophageal echocardiogram (which is
performed well in advance of surgery), and depending on the
individual surgeon’s level of comfort and expertise, we have
occasionally seen referrals between surgeons. This was somewhat
unanticipated and is an interesting process to observe. Are you
seeing similar referrals between surgeons? Also, what are your
efforts to predict complexity?
Dr LaPar. I am sorry, what was the last part?
Dr Drake. What are your efforts toward predicting the
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DDr LaPar. You question is quite interesting because we
haven’t been able to empirically examine the trends within our
organization for internal referrals.
Dr Drake. How about the discussion during your collaborative
meetings? Do the surgeons seem at all interested in referral among
themselves?1004 The Journal of Thoracic and Cardiovascular SurDr LaPar. The VCSQI certainly is interested in developing
processes of care that result in the delivery of the best patient
care. Although we haven’t directly discussed the trends of internal
referrals for mitral repair, this is certainly something that may look
into further in future collaborations.
Dr Drake. Thank you.gery c September 2014
